| Authors: |
Schiffer JT; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Reeves DB; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Mayer B; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA., Rodriguez LR; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA., Duke ER; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.; Palo Alto VA, Palto Alto, California, USA., Haddock B; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA., Avila-Ponce de Leon U; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA.; University of California, San Francisco, San Francisco, California, USA., Iwami S; Interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan., Owens K; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA., Esmaeili-Wellman S; Fred Hutchinson Cancer Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA. |
